Boston, MA -- (SBWire) -- 05/04/2013 --Tumbling over the patent cliff, many Big Pharma companies are being forced to find new strategies for sustaining sales growth, with orphan drugs seen as a great opportunity for this. Our report provides analysis of this sector and includes brands that have gained orphan drug approval from the FDA, as well as Phase III pipeline candidates that have gained orphan drug designation from the FDA.
Report Scope
- Manage expectations: Sales forecasts for the orphan drug market at the product, therapy area, molecule type, & peer set level for the period 2011-17.
- Recognize potential: 39 companies reviewed to obtain the market size for orphan drugs.
- Understand market trends: Identify the top 20 brands with FDA orphan drug approval and their forecast values for 2017.
- Identify opportunities: Analysis of the leading companies in the orphan drug space, examining their portfolios and orphan drugs in their pipelines.
- Gain insight into competitors: Novartis, J&J, Sanofi, Pfizer, AstraZeneca, Celgene, Allergan, Shire, UCB, Alexion, BioMarin, NPS Pharma, Vertex.
View Full Report Details and Table of Contents
Report Hightlights
Over 2005-11, approved orphan drugs on the market have benefitted from a healthy sales growth rate, as reflected in a 9.6% CAGR, collectively generating $86.3bn in global sales in 2011. Going forward, however, these brands will see a near-flat sales growth during the forecast window.
In terms of therapy areas, oncology is and will continue to be the largest market in terms of size, generating 42% of orphan drug sales in 2011, and is forecast to yield the highest absolute sales growth with $5.3bn over the period 2011-17.
Reasons to Get this Report
- Which Big Pharma companies have the greatest focus on orphan drugs?
- Which orphan indications are the most lucrative?
- Which companies are likely acquisition targets?
- What key orphan drug deals have taken place in recent years?
- Which company has the most aggressive M&A and in-licensing strategy for orphan drugs?
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
- Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
- Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in Canada to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in India to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in Denmark to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in New Zealand to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in Austria to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
- Drug Delivery Devices Market Outlook in Republic of Korea to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Now Available: The Orphan Drug Market Outlook to 2017
New Pharmaceuticals market report from Datamonitor: "The Orphan Drug Market Outlook to 2017"